The Risk of Coronary Heart Disease Associated With Glycosylated Hemoglobin of 6.5% or Greater Is Pronounced in the Haptoglobin 2-2 Genotype-Reference-Cited by-同舟云学术

The Risk of Coronary Heart Disease Associated With Glycosylated Hemoglobin of 6.5% or Greater Is Pronounced in the Haptoglobin 2-2 Genotype

Published:2015-10 Issue:16 Volume:66 Page:1791-1799
ISSN:0735-1097
Container-title:Journal of the American College of Cardiology
language:en
Short-container-title:Journal of the American College of Cardiology

Author:

Cahill Leah E.,Jensen Majken K.,Chiuve Stephanie E.,Shalom Hadar,Pai Jennifer K.,Flint Alan J.,Mukamal Kenneth J.,Rexrode Kathryn M.,Levy Andrew P.,Rimm Eric B.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference43 articles.

1. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes;Patel;N Engl J Med,2008

2. The effect of intensive glucose lowering therapy among major racial/ethnic groups in the Veterans Affairs Diabetes Trial;Saremi;Metabolism,2015

3. Glucose control and vascular complications in veterans with type 2 diabetes;Duckworth;N Engl J Med,2009

4. Long-term effects of intensive glucose lowering on cardiovascular outcomes;Gerstein;N Engl J Med,2011

5. Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of randomised controlled trials;Ray;Lancet,2009

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association between haptoglobin polymorphism and coronary artery disease: a meta-analysis;Frontiers in Genetics;2024-09-11

2. Haptoglobin phenotype and levels in type 2 diabetes and effects of fenofibrate;Journal of Diabetes Investigation;2024-08-22

3. Haptoglobin phenotype and intensive glycemic control for coronary artery disease risk reduction in people with type two diabetes: The Veterans Affairs Diabetes Trial;American Journal of Preventive Cardiology;2024-06

4. Haptoglobin Phenotype and Intensive Glycemic Control for Coronary Artery Disease Risk Reduction in People With Type 2 Diabetes: The ADVANCE Study;Diabetes Care;2024-03-14

5. Intensive lifestyle intervention in type 2 diabetes and risk of incident coronary artery disease for the common haptoglobin phenotypes: the Look AHEAD study;Cardiovascular Diabetology;2024-02-24